Structure of the IGF‐binding domain of the insulin‐like growth factor‐binding protein‐5 (IGFBP‐5): implications for IGF and IGF‐I receptor interactions
Open Access
- 16 November 1998
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 17 (22) , 6558-6572
Abstract
Binding proteins for insulin‐like growth factors (IGFs) IGF‐I and IGF‐II, known as IGFBPs, control the distribution, function and activity of IGFs in various cell tissues and body fluids. Insulin‐like growth factor‐binding protein‐5 (IGFBP‐5) is known to modulate the stimulatory effects of IGFs and is the major IGF‐binding protein in bone tissue. We have expressed two N‐terminal fragments of IGFBP‐5 in Escherichia coli ; the first encodes the N‐terminal domain of the protein (residues 1–104) and the second, mini‐IGFBP‐5, comprises residues Ala40 to Ile92. We show that the entire IGFBP‐5 protein contains only one high‐affinity binding site for IGFs, located in mini‐IGFBP‐5. The solution structure of mini‐IGFBP‐5, determined by nuclear magnetic resonance spectroscopy, discloses a rigid, globular structure that consists of a centrally located three‐stranded anti‐parallel β‐sheet. Its scaffold is stabilized further by two inside packed disulfide bridges. The binding to IGFs, which is in the nanomolar range, involves conserved Leu and Val residues localized in a hydrophobic patch on the surface of the IGFBP‐5 protein. Remarkably, the IGF‐I receptor binding assays of IGFBP‐5 showed that IGFBP‐5 inhibits the binding of IGFs to the IGF‐I receptor, resulting in reduction of receptor stimulation and autophosphorylation. Compared with the full‐length IGFBP‐5, the smaller N‐terminal fragments were less efficient inhibitors of the IGF‐I receptor binding of IGFs.Keywords
This publication has 80 references indexed in Scilit:
- Osteogenic Protein-1 and Insulin-Like Growth Factor I Synergistically Stimulate Rat Osteoblastic Cell Differentiation and ProliferationEndocrinology, 1997
- Retinoic Acid Inhibits Cell Growth in HPV Negative Cervical Carcinoma Cells by Induction of Insulin-like Growth Factor Binding Protein-5 (IGFBP-5) SecretionBiochemical and Biophysical Research Communications, 1997
- Insulin-like Growth Factor (IGF)-binding Protein-3 (IGFBP-3) Functions as an IGF-reversible Inhibitor of IGFBP-4 ProteolysisJournal of Biological Chemistry, 1995
- Solution structure of human insulin-like growthfactor II. Relationship to receptor and binding protein interactionsJournal of Molecular Biology, 1995
- Carboxy-Truncated Insulin-like Growth Factor-Binding Protein-5 Stimulates Mitogenesis in Osteoblast-like CellsBiochemical and Biophysical Research Communications, 1993
- Mutants of human insulin‐like growth factor IIEuropean Journal of Biochemistry, 1992
- Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF-II in human boneBiochemical and Biophysical Research Communications, 1991
- Rapid recording of 2D NMR spectra without phase cycling. Application to the study of hydrogen exchange in proteinsJournal of Magnetic Resonance (1969), 1989
- Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factorsBiochemical and Biophysical Research Communications, 1988
- Improved spectral resolution in COSY 1H NMR spectra of proteins via double quantum filteringBiochemical and Biophysical Research Communications, 1983